Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

ClinicalTrials.gov ID: NCT00067457

Public ClinicalTrials.gov record NCT00067457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects With Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy

Study identification

NCT ID
NCT00067457
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
700 participants

Conditions and interventions

Interventions

  • alosetron Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2003
Primary completion
Nov 30, 2005
Completion
Nov 30, 2005
Last update posted
Apr 15, 2015

2003 – 2005

United States locations

U.S. sites
190
U.S. states
38
U.S. cities
169
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35235
GSK Investigational Site Birmingham Alabama 35242
GSK Investigational Site Huntsville Alabama 35801
GSK Investigational Site Mobile Alabama 36693
GSK Investigational Site Pell City Alabama 35125
GSK Investigational Site Tallassee Alabama 36078
GSK Investigational Site Tucson Arizona 85712
GSK Investigational Site Little Rock Arkansas 72205
GSK Investigational Site North Little Rock Arkansas 72117
GSK Investigational Site Beverly Hills California 90211
GSK Investigational Site Carlsbad California 92008
GSK Investigational Site Concord California 94520
GSK Investigational Site Encinitas California 92024
GSK Investigational Site Fresno California 93720
GSK Investigational Site Garden Grove California 92840
GSK Investigational Site Los Angeles California 90035
GSK Investigational Site Orange California 92868
GSK Investigational Site Roseville California 95661
GSK Investigational Site San Diego California 92103
GSK Investigational Site San Diego California 92108
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Francisco California 94114
GSK Investigational Site San Francisco California 94115
GSK Investigational Site San Francisco California 94122
GSK Investigational Site Santa Ana California 92704
GSK Investigational Site Spring Valley California 91978
GSK Investigational Site Torrance California 90505
GSK Investigational Site Van Nuys California 91405
GSK Investigational Site Centennial Colorado 80112
GSK Investigational Site Colorado Springs Colorado 80909
GSK Investigational Site Littleton Colorado 80120
GSK Investigational Site Longmont Colorado 80501
GSK Investigational Site Bristol Connecticut 06010
GSK Investigational Site Belleair Bluffs Florida 33770
GSK Investigational Site Boca Raton Florida 33428
GSK Investigational Site Bradenton Florida 34209
GSK Investigational Site Clearwater Florida 33756
GSK Investigational Site Clearwater Florida 33765
GSK Investigational Site DeLand Florida 32720
GSK Investigational Site Gainesville Florida 32607
GSK Investigational Site Hollywood Florida 33021
GSK Investigational Site Jacksonville Florida 32209
GSK Investigational Site Jacksonville Florida 32256-6004
GSK Investigational Site Kissimmee Florida 34741
GSK Investigational Site Melbourne Florida 32901
GSK Investigational Site North Miami Beach Florida 33162
GSK Investigational Site Spring Hill Florida 34608
GSK Investigational Site Stuart Florida 34996
GSK Investigational Site Zephyrhills Florida 33540
GSK Investigational Site Atlanta Georgia 30328
GSK Investigational Site Atlanta Georgia 30339
GSK Investigational Site Blue Ridge Georgia 30513
GSK Investigational Site Dunwoody Georgia 30328
GSK Investigational Site Fayetteville Georgia 30214
GSK Investigational Site Rome Georgia 30165
GSK Investigational Site Savannah Georgia 31405
GSK Investigational Site Boise Idaho 83702
GSK Investigational Site Coeur d'Alene Idaho 83814
GSK Investigational Site Meridian Idaho 83642
GSK Investigational Site Chicago Illinois 60612-7323
GSK Investigational Site Chicago Illinois 60637
GSK Investigational Site Libertyville Illinois 60048
GSK Investigational Site Moline Illinois 61265
GSK Investigational Site Morton Grove Illinois 61550
GSK Investigational Site Oakbrook Terrace Illinois 60181
GSK Investigational Site Peoria Illinois 61602
GSK Investigational Site Rockford Illinois 61107
GSK Investigational Site Indianapolis Indiana 46208
GSK Investigational Site Indianapolis Indiana 46237
GSK Investigational Site Jeffersonville Indiana 47130
GSK Investigational Site Clive Iowa 50325
GSK Investigational Site Haysville Kansas 67060
GSK Investigational Site Kansas City Kansas 66160
GSK Investigational Site Wichita Kansas 67203
GSK Investigational Site Florence Kentucky 41042
GSK Investigational Site Lexington Kentucky 40508
GSK Investigational Site Lexington Kentucky 40536
GSK Investigational Site Madisonville Kentucky 42431
GSK Investigational Site Covington Louisiana 70433
GSK Investigational Site Lafayette Louisiana 70508
GSK Investigational Site Monroe Louisiana 71201
GSK Investigational Site New Orleans Louisiana 70112
GSK Investigational Site New Orleans Louisiana 70128
GSK Investigational Site Shreveport Louisiana 71103
GSK Investigational Site Annapolis Maryland 21401
GSK Investigational Site Baltimore Maryland 21215
GSK Investigational Site Baltimore Maryland 21229
GSK Investigational Site Lanham Maryland 20706
GSK Investigational Site Oxon Hill Maryland 20745
GSK Investigational Site Severna Park Maryland 21146
GSK Investigational Site Silver Spring Maryland 20910
GSK Investigational Site Towson Maryland 21204-7736
GSK Investigational Site Towson Maryland 21204
GSK Investigational Site Wheaton Maryland 20906
GSK Investigational Site Burlington Massachusetts 01805
GSK Investigational Site Farmington Hills Michigan 48334
GSK Investigational Site Northville Michigan 48167
GSK Investigational Site Petoskey Michigan 49770
GSK Investigational Site Saginaw Michigan 48602
GSK Investigational Site Brooklyn Center Minnesota 55430
GSK Investigational Site Chesterfield Missouri 63017
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Lincoln Nebraska 68503
GSK Investigational Site Omaha Nebraska 68144
GSK Investigational Site Las Vegas Nevada 89119
GSK Investigational Site Berlin New Jersey 08009
GSK Investigational Site Blackwood New Jersey 08012
GSK Investigational Site Cedar Knolls New Jersey 7927
GSK Investigational Site Oakhurst New Jersey 07755
GSK Investigational Site Passaic New Jersey 07055
GSK Investigational Site South Bound Brook New Jersey 08880
GSK Investigational Site Willingboro New Jersey 08046
GSK Investigational Site Albuquerque New Mexico 87106
GSK Investigational Site Albany New York 12205
GSK Investigational Site Binghamton New York 13901
GSK Investigational Site Endwell New York 13760
GSK Investigational Site Great Neck New York 11023
GSK Investigational Site Pittsford New York 14534
GSK Investigational Site Pomona New York 10970
GSK Investigational Site Cary North Carolina 27511
GSK Investigational Site Charlotte North Carolina 28262
GSK Investigational Site Gastonia North Carolina 28054
GSK Investigational Site Greensboro North Carolina 27403
GSK Investigational Site Greenville North Carolina 27858
GSK Investigational Site Jacksonville North Carolina 28546
GSK Investigational Site Raleigh North Carolina 27609
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Wilmington North Carolina 28412
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Bellbrook Ohio 45305
GSK Investigational Site Cincinnati Ohio 45236
GSK Investigational Site Columbus Ohio 43207
GSK Investigational Site Columbus Ohio 43215
GSK Investigational Site Wandsworth Ohio 44281
GSK Investigational Site Oklahoma City Oklahoma 73112
GSK Investigational Site Tulsa Oklahoma 74135
GSK Investigational Site Portland Oregon 97210
GSK Investigational Site Portland Oregon 97225
GSK Investigational Site Bensalem Pennsylvania 19020
GSK Investigational Site Duncansville Pennsylvania 16635
GSK Investigational Site Feasterville Pennsylvania 19053
GSK Investigational Site Levittown Pennsylvania 19057
GSK Investigational Site Media Pennsylvania 19063
GSK Investigational Site Morrisville Pennsylvania 19067
GSK Investigational Site Penndel Pennsylvania 19047
GSK Investigational Site Philadelphia Pennsylvania 19106
GSK Investigational Site Philadelphia Pennsylvania 19107
GSK Investigational Site Philadelphia Pennsylvania 19148
GSK Investigational Site Pittsburgh Pennsylvania 15218
GSK Investigational Site Reading Pennsylvania 19611
GSK Investigational Site Sellersville Pennsylvania 18960
GSK Investigational Site Stoneboro Pennsylvania 16153
GSK Investigational Site Anderson South Carolina 29621
GSK Investigational Site Charleston South Carolina 29407
GSK Investigational Site Summerville South Carolina 29485
GSK Investigational Site Sioux Falls South Dakota 57105
GSK Investigational Site Bristol Tennessee 37620
GSK Investigational Site Clarksville Tennessee 37043
GSK Investigational Site Jackson Tennessee 38305
GSK Investigational Site Johnson City Tennessee 37601
GSK Investigational Site Kingsport Tennessee 37660
GSK Investigational Site Knoxville Tennessee 37920
GSK Investigational Site Memphis Tennessee 38119
GSK Investigational Site Nashville Tennessee 37205
GSK Investigational Site Austin Texas 78758
GSK Investigational Site Conroe Texas 77304
GSK Investigational Site Dallas Texas 75230
GSK Investigational Site Houston Texas 77024
GSK Investigational Site Humble Texas 77338
GSK Investigational Site North Richland Hills Texas 76180
GSK Investigational Site Pasadena Texas 77505
GSK Investigational Site San Antonio Texas 78205
GSK Investigational Site San Antonio Texas 78229
GSK Investigational Site Sugar Land Texas 77478
GSK Investigational Site The Woodlands Texas 77381
GSK Investigational Site Salt Lake City Utah 84132
GSK Investigational Site Chesapeake Virginia 23320
GSK Investigational Site Christiansburg Virginia 24073
GSK Investigational Site Danville Virginia 24541
GSK Investigational Site Norfolk Virginia 23502
GSK Investigational Site Norfolk Virginia 23507
GSK Investigational Site Richmond Virginia 23294
GSK Investigational Site Virginia Beach Virginia 23455
GSK Investigational Site Weber City Virginia 24290
GSK Investigational Site Bellevue Washington 98004
GSK Investigational Site Gig Harbor Washington 98335
GSK Investigational Site Lacey Washington 98516
GSK Investigational Site Tacoma Washington 98405
GSK Investigational Site La Crosse Wisconsin 54601
GSK Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00067457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00067457 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →